Skip to content

A Study on Tumor Budding Guiding Individualized Surgical Planning of Early-stage Oral Squamous Cell Carcinoma.

A Randomized,Multicenter,Prospectie,Controlled Clinical Study on Tumor Budding Guiding Individualized Surgical Planning of Early-stage Oral Squamous Cell Carcinoma.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02743832
Enrollment
524
Registered
2016-04-19
Start date
2026-05-04
Completion date
2027-06-30
Last updated
2026-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carcinoma, Squamous Cell

Keywords

Oral squamous cell carcinoma, Tumor budding, Cervical lymph node dissection

Brief summary

The purpose of this study is to determine whether cervical lymph node dissection is necessarily performed in the presence of early-stage oral squamous cell carcinoma.

Detailed description

Oral squamous cell carcinoma is the most common malignant tumor of oral and maxillofacial region, and prone to early cervical lymph node metastases. Lymphatic spread is associated with increased risk of loco-regional recurrence, therefore, the identification of lymph node metastases preoperatively is very important for the optimal surgical therapy. Recently, cervical lymph node dissection(CLND) is performed in the presence of oral squamous cell carcinoma. However, whether cervical lymph node dissection is necessarily performed in the presence of early-stage oral squamous cell carcinoma is still controversial. CLND will represent over-treatment in some case of early-stage oral squamous cell carcinoma. Therefore, How to accurately predict whether a patient should be performed CLND is important. Our previous study show that tumor budding is closely related to lymphatic spread in the oral squamous cell carcinoma. The purpose of this study is to find that whether the tumor budding guide the individualized surgical planning of early-stage oral squamous cell carcinoma.

Interventions

PROCEDUREResection for primary lesion and cervical lymph node dissection

Resection for primary lesion and cervical lymph node dissection are performed in the early-stage oral squamous cell carcinoma.

PROCEDUREResection for primary lesion only

Only resection for primary lesion is performed in the early-stage oral squamous cell carcinoma.

Sponsors

Jinsong Hou
Lead SponsorOTHER
First Affiliated Hospital, Sun Yat-Sen University
CollaboratorOTHER
Second Affiliated Hospital, Sun Yat-Sen University
CollaboratorOTHER
Hospital of Stomatology, Sun Yat-Sen University
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

1. Han race; 2. Oral squamous cell carcinoma is confirmed by pathology; 3. The section of oral squamous cell carcinoma including primary two-thirds prior to the tongue, buccal mucosa, gingiva, mouth floor, hard palate mucosa; 4. The primary lesion is no more than 4cm; 5. Do not find cervical lymph node metastases and distant metastasis in the clinical examination including physical examination and MRI; 6. Patients and families agree to participate in the study; 7. Patients do not have cognitive disorders.

Exclusion criteria

1. Do not meet the inclusion criteria; 2. The primary lesion is more than 4cm or invade adjacent tissues; 3. Do not review on schedule; 4. Patients receive not only surgical procedures, but other antineoplastic treatment; 5. There are serious adverse events after operation; 6. Patients quit the study voluntarily; 7. Patients quit the study because of physical condition.

Design outcomes

Primary

MeasureTime frameDescription
Five-year survival rateAfter the first year, review every three months at a time;The next four years, review every six months at a time.The time from the first operation to death was recorded
Disease free survivalAfter the first year, review every three months at a time;The next four years, review every six months at a time.The time from the start of surgery to the discovery of the first cervical lymphatic metastases

Secondary

MeasureTime frameDescription
Recurrence rateAfter the first year, review every three months at a time;The next four years, review every six months at a time.To investigate the local recurrence rate and the recurrence rate of cervical lymphatic metastasis.
Evaluation of quality of lifeAfter the first year, review every three months at a time;The next four years, review every six months at a time.Complete the University of Washington Quality of Life Form (UW-QOL) To understand the quality of life of patients after surgery.

Countries

China

Contacts

CONTACTJinsong Hou, PhD
houjsgz@aliyun.com86-13825141651
CONTACTCheng Wang, PhD
drwangcheng@outlook.com86-13760853366
STUDY_DIRECTORJinsong Hou, PhD

Guanghua School of Stomatology, Hospital of Stomatolagy Sun Yat-sen University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 1, 2026